Gengos Andrew

EDGAR CIK 0001563623

Terns Pharmaceuticals, Inc. - TERN

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
3
$96,366
25,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/27/2025
06/30/2025
Buy
10,000 @ $3.93
 $39,283 25,000 (66.67%) Direct
06/16/2025
06/16/2025
Buy
5,000 @ $3.95
 $19,732 15,000 (50.00%) Direct
06/13/2025
06/16/2025
Buy
10,000 @ $3.73
 $37,350 10,000 (100.00%) Direct

Athira Pharma, Inc. - ATHA

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
CFO and Chief Business Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($720)
-1,272 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/05/2024
09/05/2024
Sell
-1,272 @ $0.57
 ($720) 97,532 (-1.29%) Direct